α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor

被引:1
|
作者
Suominen, Anni [1 ,2 ]
Saldo Rubio, Guillem [1 ]
Ruohonen, Saku [1 ]
Szabo, Zoltan [3 ]
Pohjolainen, Lotta [4 ,5 ]
Ghimire, Bishwa [6 ,7 ]
Ruohonen, Suvi [1 ]
Saukkonen, Karla [1 ]
Ijas, Jani [1 ]
Skarp, Sini [3 ]
Kaikkonen, Leena [3 ]
Cai, Minying [8 ]
Wardlaw, Sharon [9 ]
Ruskoaho, Heikki [4 ,5 ]
Talman, Virpi [4 ,5 ]
Savontaus, Eriika [1 ,10 ,11 ]
Kerkelae, Risto [3 ,12 ,13 ,14 ]
Rinne, Petteri [1 ,10 ]
机构
[1] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku, Finland
[2] Univ Turku, Drug Res Doctoral Programme DRDP, Turku, Finland
[3] Univ Oulu, Dept Pharmacol & Toxicol, Res Unit Biomed & Internal Med, Oulu, Finland
[4] Univ Helsinki, Fac Pharm, Drug Res Program, Helsinki, Finland
[5] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Helsinki, Finland
[6] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE Helsinki Inst Life Sci, Helsinki Inst Life Sci HiLIFE, Helsinki, Finland
[7] Univ Turku, Fac Med, Turku, Finland
[8] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA
[9] Columbia Univ, Dept Med, Vagelos Coll Phys & Surg, New York, NY USA
[10] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland
[11] Turku Univ Hosp, Unit Clin Pharmacol, Turku, Finland
[12] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland
[13] Univ Oulu, Oulu, Finland
[14] Univ Oulu, Bioctr Oulu, Oulu, Finland
基金
芬兰科学院; 美国国家卫生研究院;
关键词
Melanocyte-stimulating Hormone; Melanocortin Receptor; Hypertrophy; Heart Failure; Fibrosis; PRESSURE-OVERLOAD; SIGNALING MECHANISMS; ANGIOTENSIN-II; HYPERTROPHY; GROWTH; DYSFUNCTION; CLONING; DESIGN; POTENT; EXPRESSION;
D O I
10.1038/s44319-024-00109-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Melanocyte-stimulating hormone (alpha-MSH) regulates diverse physiological functions by activating melanocortin receptors (MC-R). However, the role of alpha-MSH and its possible target receptors in the heart remain completely unknown. Here we investigate whether alpha-MSH could be involved in pathological cardiac remodeling. We found that alpha-MSH was highly expressed in the mouse heart with reduced ventricular levels after transverse aortic constriction (TAC). Administration of a stable alpha-MSH analog protected mice against TAC-induced cardiac hypertrophy and systolic dysfunction. In vitro experiments revealed that MC5-R in cardiomyocytes mediates the anti-hypertrophic signaling of alpha-MSH. Silencing of MC5-R in cardiomyocytes induced hypertrophy and fibrosis markers in vitro and aggravated TAC-induced cardiac hypertrophy and fibrosis in vivo. Conversely, pharmacological activation of MC5-R improved systolic function and reduced cardiac fibrosis in TAC-operated mice. In conclusion, alpha-MSH is expressed in the heart and protects against pathological cardiac remodeling by activating MC5-R in cardiomyocytes. These results suggest that analogs of naturally occurring alpha-MSH, that have been recently approved for clinical use and have agonistic activity at MC5-R, may be of benefit in treating heart failure. alpha-Melanocyte-stimulating hormone (alpha-MSH) regulates several physiological functions by interacting with melanocortin receptors (MC1-R-MC5-R). This study shows that alpha-MSH is expressed in the heart and it protects against pathological cardiac remodeling by activating MC5-R in cardiomyocytes.alpha-MSH production declines in the failing mouse heart. Pharmacological administration of alpha-MSH alleviates pathological cardiac hypertrophy induced by pressure overload. The protective effects of alpha-MSH are mediated by the melanocortin 5 receptor (MC5-R), which is expressed in mouse and human cardiac myocytes. Silencing MC5-R in cardiomyocytes renders mice susceptible to cardiac hypertrophy and fibrosis after pressure overload. alpha-Melanocyte-stimulating hormone (alpha-MSH) regulates several physiological functions by interacting with melanocortin receptors (MC1-R-MC5-R). This study shows that alpha-MSH is expressed in the heart and it protects against pathological cardiac remodeling by activating MC5-R in cardiomyocytes.
引用
收藏
页码:1987 / 2014
页数:28
相关论文
共 50 条
  • [1] Potent and selective agonists of human melanocortin receptor 5:: Cyclic analogues of α-melanocyte-stimulating hormone
    Bednarek, Maria A.
    MacNeil, Tanya
    Tang, Rui
    Fong, Tung M.
    Cabello, M. Angeles
    Maroto, Marta
    Teran, Ana
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) : 2520 - 2526
  • [2] MELANOCYTE-STIMULATING HORMONE
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1977, 1 (6060): : 533 - 533
  • [3] MELANOCYTE-STIMULATING HORMONE AND PARKINSONISM
    SHUSTER, S
    BURTON, JL
    THODY, AJ
    PLUMMER, N
    GOOLAMALI, SK
    BATES, D
    LANCET, 1973, 1 (7806): : 768 - 768
  • [4] MELANOCYTE-STIMULATING HORMONE AND CORTICOTROPHIN
    不详
    BRITISH MEDICAL JOURNAL, 1957, 1 (APR20): : 935 - 936
  • [5] MELANOCYTE-STIMULATING HORMONE AND PARKINSONISM
    SHUSTER, S
    THODY, AJ
    GOOLAMALI, SK
    BURTON, JL
    PLUMMER, N
    BATES, D
    LANCET, 1973, 1 (7801): : 463 - 464
  • [6] STIMULATION OF THE RECEPTOR FOR MELANOCYTE-STIMULATING HORMONE BY RETINOIC ACID
    CHAKRABORTY, AK
    ORLOW, SJ
    PAWELEK, JM
    FEBS LETTERS, 1990, 276 (1-2) : 205 - 208
  • [7] MELANOCYTE-STIMULATING HORMONE AND PARKINSONISM
    ROBINS, AH
    LANCET, 1973, 1 (7805): : 727 - 727
  • [8] MSH - THE MELANOCYTE-STIMULATING HORMONE
    LERNER, AB
    SHIZUME, K
    FITZPATRICK, TB
    MASON, HS
    AMA ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1954, 70 (05): : 669 - 674
  • [9] Evidence for expression of the melanocortin-1 receptor and an immunoregulatory role of α-melanocyte-stimulating hormone in human basophils
    Böhm, M
    Wolff, I
    Scholzen, TE
    Luger, TA
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) : 246 - 246
  • [10] Pivotal roles of α-melanocyte-stimulating hormone and the melanocortin 4 receptor in leptin stimulation of prolactin secretion in rats
    Watanobe, H
    Schiöth, HB
    Izumi, J
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 (02) : 338 - 347